RESPONSE BIOMEDICAL , founded in 1991. Develops, manufactures and markets the RAMP ® system. The RAMP® System is an immunoassay platform that provides information in minutes. Rapid diagnostic platform that delivers lab-quality performance for efficient patient management in acute care settings. 100% of RAMP® tests and instruments are made in Canada. It is marketed in 35 countries and continues to expand.

Specifications

RAMP® 200

A high-performance multi-port laboratory reader

Specifications

RAMP® Reader

True point-of-care testing solution. Completely portable and lightweight reader.

Each cartridge is a quantitative immunochromatographic test that determines the concentration of a cardiac marker in EDTA whole blood, or an infectious disease – including Sepsis.

RAMP® Test Panel

Cardiovascular

infectious

sepsis

Biodefense

Environment

COVID-19 Antigen Test

D-DIMER

TROPONIN I (TnI)

PROCALCITONIN (PCT)

CK-MB

NT-proBNP

Biomarker of pregnancy (b-hCG)

The RAMP® Platform

offers a comprehensive solution for Hospitals, Critical Care Units and Laboratories – to perform IVD diagnostic tests – on site, with the precision of large laboratory analyzers and the speed and simplicity of use of Point of Care equipment.

Play Video

RAMP® Reagent Kit

The platform is made up of one of the analyzers, either RAMP® Reader or RAMP® 200, in addition to the test cartridges that individually give results for a specific parameter.